allogene.com

Website review allogene.com

Home - Allogene

 Generated on April 10 2026 06:02 AM

Old data? UPDATE !

The score is 49/100

SEO Content

Title

Home - Allogene

Length : 15

Perfect, your title contains between 10 and 70 characters.

Description

Length : 0

Very bad. We haven't found meta description on your page. Use this free online meta tags generator to create description.

Keywords

Very bad. We haven't found meta keywords on your page. Use this free online meta tags generator to create keywords.

Og Meta Properties

Good, your page take advantage of Og Properties.

Property Content
locale en_US
type website
title Home - Allogene
description REDEFINING THE FUTURE OF CELL THERAPY WITH OUR AlloCAR T PRODUCT PLATFORM INNOVATION Multiplex gene-engineering and gene-editing capabilities Proprietary lymphodepletion platform State-of-the-art manufacturing Opportunity for product optimization SEE OUR PIONEERING PLATFORM >> KEY PROGRAMS Cemacabtagene ansegedleucel (cema-cel): Frontline treatment in LBCL, including diffuse large B-cell lymphoma (DLBCL) ALLO-316: ccRCC ALLO-329: autoimmune disease EXPLORE OUR PIPELINE >> LEADERSHIP A […]
url https://allogene.com/
site_name Allogene
image https://allogene.com/wp-content/uploads/2021/09/innovation.png

Headings

H1 H2 H3 H4 H5 H6
4 10 21 0 0 0
  • [H1] RESOLUTION
  • [H1] REDEFINING THE FUTURE OF CAR T
  • [H1] RESOLUTION
  • [H1] REDEFINING THE FUTURE OF CAR T
  • [H2] NOW ENROLLING
  • [H2] NOW ENROLLING
  • [H2] Now Enrolling
  • [H2] NOW ENROLLING
  • [H2] REDEFINING THE FUTURE OF CELL THERAPY WITH OUR AlloCAR T PRODUCT PLATFORM
  • [H2] WE DON’T JUST SEE THE FUTURE.
  • [H2] WE KNOW HOW TO GET THERE.
  • [H2] WHY ALLOGENEIC CELL PRODUCTS HAVE THE POTENTIAL TO DO WHAT NO AUTOLOGOUS CAR T HAS DONE BEFORE
  • [H2] OUR PARTNERS
  • [H2] LATEST NEWS
  • [H3] INNOVATION
  • [H3] KEY PROGRAMS
  • [H3] LEADERSHIP
  • [H3] ACCESS
  • [H3] COST
  • [H3] SPEED/RELIABILITY
  • [H3] INNOVATION
  • [H3] Mar 12, 2026
  • [H3] Mar 2, 2026
  • [H3] Feb 5, 2026
  • [H3] Jan 8, 2026
  • [H3] Dec 15, 2025
  • [H3] Nov 10, 2025
  • [H3] Nov 6, 2025
  • [H3] Nov 3, 2025
  • [H3] Oct 30, 2025
  • [H3] Aug 27, 2025
  • [H3] Aug 13, 2025
  • [H3] Aug 6, 2025
  • [H3] CONNECT
  • [H3] CONNECT

Images

We found 18 images on this web page.

3 alt attributes are empty or missing. Add alternative text so that search engines can better understand the content of your images.

Text/HTML Ratio

Ratio : 1%

This page's ratio of text to HTML code is below 15 percent, this means that your website probably needs more text content.

Flash

Perfect, no Flash content has been detected on this page.

Iframe

Great, there are no Iframes detected on this page.

URL Rewrite

Good. Your links looks friendly!

Underscores in the URLs

Perfect! No underscores detected in your URLs.

In-page links

We found a total of 71 links including 0 link(s) to files

Anchor Type Juice
Skip to content Internal Passing Juice
CONTACT US Internal Passing Juice
CAREERS Internal Passing Juice
PIPELINE Internal Passing Juice
AlloCAR T PRODUCT PIPELINE Internal Passing Juice
THE ALPHA3 TRIAL Internal Passing Juice
THE RESOLUTION TRIAL Internal Passing Juice
DATABRIEF Internal Passing Juice
EXPANDED ACCESS Internal Passing Juice
SCIENCE Internal Passing Juice
NEXT REVOLUTION IN CELL THERAPY Internal Passing Juice
PLATFORM FOR TOMORROW Internal Passing Juice
ON-DEMAND AVAILABILITY Internal Passing Juice
SCIENTIFIC PUBLICATIONS Internal Passing Juice
ABOUT US Internal Passing Juice
AT A GLANCE Internal Passing Juice
MANAGEMENT TEAM Internal Passing Juice
BOARD OF DIRECTORS Internal Passing Juice
SCIENTIFIC ADVISORS Internal Passing Juice
PARTNERS Internal Passing Juice
CORPORATE RESPONSIBILITY Internal Passing Juice
NEWS CENTER Internal Passing Juice
PRESS RELEASES Internal Passing Juice
EVENTS Internal Passing Juice
PERSPECTIVES Internal Passing Juice
SOCIAL MEDIA Internal Passing Juice
COMMUNITY GUIDELINES Internal Passing Juice
INVESTORS Internal Passing Juice
NEWS & EVENTS Internal Passing Juice
PRESS RELEASES Internal Passing Juice
EVENTS Internal Passing Juice
PRESENTATIONS Internal Passing Juice
STOCK QUOTE & CHART Internal Passing Juice
HISTORIC PRICE LOOKUP Internal Passing Juice
INVESTMENT CALCULATOR Internal Passing Juice
DOCUMENTS & CHARTERS Internal Passing Juice
BOARD OF DIRECTORS Internal Passing Juice
MANAGEMENT Internal Passing Juice
COMMITTEE COMPOSITION Internal Passing Juice
SEC FILINGS Internal Passing Juice
INVESTOR FAQs Internal Passing Juice
EMAIL ALERTS Internal Passing Juice
IR INQUIRY Internal Passing Juice
Allogene Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Update Internal Passing Juice
Allogene Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update Internal Passing Juice
Allogene Therapeutics Announces Participation in Upcoming Investor Conferences Internal Passing Juice
Allogene Therapeutics Positions 2026 as a Program-Defining Year for Scalable, Real-World Allogeneic CAR T Internal Passing Juice
Allogene Therapeutics Reports Favorable Result for Servier in Arbitration with Cellectis Internal Passing Juice
Allogene Therapeutics Announces Participation in Upcoming Investor Conferences Internal Passing Juice
Allogene Therapeutics Reports Third Quarter 2025 Financial Results and Business Update Internal Passing Juice
Allogene Therapeutics Announces ALPHA3 Trial-in-Progress Poster Presentation at ASH Annual Meeting Internal Passing Juice
Allogene Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update Internal Passing Juice
Allogene Therapeutics Announces Participation in Upcoming Investor Conference Internal Passing Juice
Allogene Therapeutics Reports Second Quarter 2025 Financial Results and Business Update Internal Passing Juice
Allogene Therapeutics to Report Second Quarter 2025 Financial Results and Provide Business Update Internal Passing Juice
View Map Internal Passing Juice
Contact Us Internal Passing Juice
PIPELINE Internal Passing Juice
AlloCAR T Product Pipeline Internal Passing Juice
Expanded Access Internal Passing Juice
Scientific Publications Internal Passing Juice
At a Glance Internal Passing Juice
Management Team Internal Passing Juice
Press Releases Internal Passing Juice
Events Internal Passing Juice
Perspectives Internal Passing Juice
Social Media Internal Passing Juice
Corporate Governance Internal Passing Juice
INVESTORS Internal Passing Juice
TERMS OF USE Internal Passing Juice
PRIVACY NOTICE Internal Passing Juice

SEO Keywords

Keywords Cloud

allogeneic allogene car trial learn more events management cell therapeutics

Keywords Consistency

Keyword Content Title Keywords Description Headings
learn 17
more 16
allogene 12
therapeutics 12
cell 10

Usability

Url

Domain : allogene.com

Length : 12

Favicon

Great, your website has a favicon.

Printability

We could not find a Print-Friendly CSS.

Language

Good. Your declared language is en.

Dublin Core

This page does not take advantage of Dublin Core.

Document

Doctype

HTML 5

Encoding

Perfect. Your declared charset is UTF-8.

W3C Validity

Errors : 0

Warnings : 0

Email Privacy

Warning! At least one email address has been found in the plain text. Use free antispam protector to hide email from spammers.

Deprecated HTML

Great! We haven't found deprecated HTML tags in your HTML.

Speed Tips

Excellent, your website doesn't use nested tables.
Too bad, your website is using inline styles.
Too bad, your website has too many CSS files (more than 4).
Too bad, your website has too many JS files (more than 6).
Perfect, your website takes advantage of gzip.

Mobile

Mobile Optimization

Apple Icon
Meta Viewport Tag
Flash content

Optimization

XML Sitemap

Great, your website has an XML sitemap.

https://allogene.com/sitemap_index.xml

Robots.txt

https://allogene.com/robots.txt

Great, your website has a robots.txt file.

Analytics

Great, your website has an analytics tool.

   Google Analytics

PageSpeed Insights


Device
Categories

Free SEO Testing Tool

Free SEO Testing Tool is a free SEO tool which provides you content analysis of the website.